It seems intuitive, if not obvious, that superior imaging of the prostate gives precise information to guide a biopsy needle into a cancerous tumor. The typical ultrasound imaging used by urologists in their offices is inferior to magnetic resonance imaging (MRI). Ultrasound-guided transrectal (TRUS) biopsy has a minimum 35% chance of missing cancer. If our keep reading